Pharmacoeconomics and Clinical Practice Guidelines
- 118 Downloads
Background: Swedish formulary committees are expected to influence prescribing practice by establishing and issuing drug lists and clinical practice guidelines, particularly now that financial responsibility for prescription drugs has been transferred from the national to the county council level.
Objective: The purpose of this exploratory study was to identify the information sources and decision criteria that individual committee members perceive as important in establishing clinical practice guidelines. Moreover, obstacles to the increased use of pharmacoeconomic evaluations in decision-making were also identified.
Design and setting: Data were gathered through a survey questionnaire administered in 1998 to members of central formulary committees throughout Sweden, as determined by a national register.
Participants: 312 members of central formulary committees, of whom 69% responded.
Results: Treatment policies/guidelines supplied by government authorities, or found in reviewed journals, are considered the most important sources of information, and criteria associated with costs and effects are considered themost important decision criteria. The members’ years of experience and their professions affect their assessments of information sources, whereas education in health economics affects their assessments of decision criteria. Committee members voiced an interest in pharmacoeconomic issues, but warned that there was neither sufficient competence among committee members nor an adequate supply of relevant studies. Furthermore, a majority of the members identified difficulty in translating study results into clinical practice guidelines and limited possibilities in comparing studies as obstacles to the increased use of pharmacoeconomic evaluations.
Conclusions: The results of this survey may be useful in designing future economic evaluations and when presenting and diffusing study results.
KeywordsInformation Source National Health Service Decision Criterion Committee Member County Council
This study was funded by the National Corporation of Swedish Pharmacies and the Swedish Federation of County Councils.
- 1.Pritchard C. Trends in economic evaluation: OHE briefing No. 36. London: Office of Health Economics, 1998Google Scholar
- 2.Sloan FA, Grabowski HG, editors. The impact of cost-effectiveness on public and private policies in health care: an international perspective. Soc Sci Med 1997; 45 (4)Google Scholar
- 4.Reform på recept, Delbetänkande av HSU 2000. Stockholm: SOU, 1995: 122Google Scholar
- 5.Nordling S. Hur långt har inforandet av läkemedelsreformen kommit i landstingen?: redovisning av enkätstudie våren 1997. Stockholm: Spri, 1997Google Scholar
- 9.Dillman DA. Mail and telephone surveys: the total design method. New York: Wiley, 1978Google Scholar
- 10.Hair Jr JF, Anderson RE, Tatham RL, et al. Multivariate data analysis with readings. Upper Saddle River (NJ): Prentice Hall, 1995Google Scholar